Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Pilot study to investigate dietary supplementation of elderly COPD patients with an oral nutritional supplement enriched with n-3 polyunsaturated fatty acids and its effect on respiratory function, appetite and weight.
ISRCTN ISRCTN16343749
ClinicalTrials.gov identifier
Public title Pilot study to investigate dietary supplementation of elderly COPD patients with an oral nutritional supplement enriched with n-3 polyunsaturated fatty acids and its effect on respiratory function, appetite and weight.
Scientific title
Acronym N/A
Serial number at source N0016148139
Study hypothesis Does the addition of fish oil to a complete nutritional supplement make supplementation more effective? i.e. do patients gain more weight, improve their lung function and exercise tolerance and report improved appetite when compared to patients using supplements without fish oils?
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Chronic obstructive pulmonary disease (COPD)
Participants - inclusion criteria Out patients from COPD clinic at the Hammersmith Hospitals NHS Trust
Participants - exclusion criteria Does not meet inclusion criteria
Anticipated start date 01/07/2002
Anticipated end date 01/07/2003
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Randomised controlled trial
Primary outcome measure(s) 1. Improved lung function
2. Decreased sytokine responses.
Fish oils have been used with promising results in other wasting conditions such as HIV, cancer and sepsis. There are no published trials investigating the possible benefits of fish oil supplementation in COPD patients and this proposal aims to do this.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding 1. Hammersmith Hospital NHS Trust (UK)
2. Hammersmith Hospital Trustees Research Committee (HHTRC) (UK)
Trial website
Publications
Contact name Dr  Gary  Frost
  Address Nutrition & Dietetics Department
2nd Floor, C Block
Hammersmith Hospital
Du Cane Road
  City/town London
  Zip/Postcode W12 0HS
  Country United Kingdom
  Tel +44 (0)20 8383 3048(bleep 9027)
  Fax +44 (0)20 8383 3379
  Email g.frost@imperial.ac.uk
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 22/09/2009
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central